Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial

Abstract Background There are complicated mechanisms that link the disruption of the gut microbiome to the symptoms and complications of polycystic ovary syndrome (PCOS). In this study, an attempt was made to assess the effects of synbiotics on the health-related quality of life (HRQoL) in women wit...

Full description

Bibliographic Details
Main Authors: Zahra Hariri, Zahra Yari, Sedighe Hoseini, Khadijeh Abhari, Golbon Sohrab
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Women's Health
Subjects:
Online Access:https://doi.org/10.1186/s12905-023-02868-1
_version_ 1827388204081217536
author Zahra Hariri
Zahra Yari
Sedighe Hoseini
Khadijeh Abhari
Golbon Sohrab
author_facet Zahra Hariri
Zahra Yari
Sedighe Hoseini
Khadijeh Abhari
Golbon Sohrab
author_sort Zahra Hariri
collection DOAJ
description Abstract Background There are complicated mechanisms that link the disruption of the gut microbiome to the symptoms and complications of polycystic ovary syndrome (PCOS). In this study, an attempt was made to assess the effects of synbiotics on the health-related quality of life (HRQoL) in women with PCOS . Methods Fifty-six women with PCOS were enrolled in a triple-blind controlled trial for 12 weeks. They were randomly assigned to receive a daily 2-gram synbiotic sachets (containing Bacillus coagulans (GBI-30), Lactobacillus rhamnosus, Lactobacillus helveticus, and fructooligosaccharide) (n = 28) or placebo (n = 28). To evaluate the impact on the HRQoL, participants were required to fill 26-Item Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ-26), 12-Item Short-Form Health Survey (SF-12) and Perceived Stress Scale (PSS-10) pre and post the intervention. Results Finally, statistical analyses were performed on 52 participants who finished the trial. Synbiotic supplementation improved the scores of emotional (P = 0.044), body hair (P = 0.016), weight (P = 0.033) and infertility domains (P = 0.027) of PCOSQ-26 compared to placebo group. The physical score within SF-12 also had a significant enhancement (P = 0.035). No significant improvement was seen in the PSS-10 score at the end of the trial. Conclusion This study illustrated the advantageous effects of synbiotics on the health-related quality of life in women with PCOS. Further studies are required to confirm our findings. Trial registration http://www.irct.ir : IRCT20211108053007N1; date of registration: 14/02/2023.
first_indexed 2024-03-08T16:14:43Z
format Article
id doaj.art-c266956fe37a449b91d52c5f18f81e51
institution Directory Open Access Journal
issn 1472-6874
language English
last_indexed 2024-03-08T16:14:43Z
publishDate 2024-01-01
publisher BMC
record_format Article
series BMC Women's Health
spelling doaj.art-c266956fe37a449b91d52c5f18f81e512024-01-07T12:42:47ZengBMCBMC Women's Health1472-68742024-01-0124111010.1186/s12905-023-02868-1Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trialZahra Hariri0Zahra Yari1Sedighe Hoseini2Khadijeh Abhari3Golbon Sohrab4Student Research Committee, Department of Clinical Nutrition and dietetics, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical SciencesDepartment of Nutrition Research, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical SciencesDepartment of Obstetrics and Gynecology, Preventative Gynecology Research Center, Shahid Beheshti University of Medical SciencesDepartment of Food Sciences and Technology, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical SciencesClinical Nutrition and dietetics Department, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical SciencesAbstract Background There are complicated mechanisms that link the disruption of the gut microbiome to the symptoms and complications of polycystic ovary syndrome (PCOS). In this study, an attempt was made to assess the effects of synbiotics on the health-related quality of life (HRQoL) in women with PCOS . Methods Fifty-six women with PCOS were enrolled in a triple-blind controlled trial for 12 weeks. They were randomly assigned to receive a daily 2-gram synbiotic sachets (containing Bacillus coagulans (GBI-30), Lactobacillus rhamnosus, Lactobacillus helveticus, and fructooligosaccharide) (n = 28) or placebo (n = 28). To evaluate the impact on the HRQoL, participants were required to fill 26-Item Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ-26), 12-Item Short-Form Health Survey (SF-12) and Perceived Stress Scale (PSS-10) pre and post the intervention. Results Finally, statistical analyses were performed on 52 participants who finished the trial. Synbiotic supplementation improved the scores of emotional (P = 0.044), body hair (P = 0.016), weight (P = 0.033) and infertility domains (P = 0.027) of PCOSQ-26 compared to placebo group. The physical score within SF-12 also had a significant enhancement (P = 0.035). No significant improvement was seen in the PSS-10 score at the end of the trial. Conclusion This study illustrated the advantageous effects of synbiotics on the health-related quality of life in women with PCOS. Further studies are required to confirm our findings. Trial registration http://www.irct.ir : IRCT20211108053007N1; date of registration: 14/02/2023.https://doi.org/10.1186/s12905-023-02868-1Polycystic ovary syndromeHealth-related quality of lifeSynbioticBacillus coagulans
spellingShingle Zahra Hariri
Zahra Yari
Sedighe Hoseini
Khadijeh Abhari
Golbon Sohrab
Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
BMC Women's Health
Polycystic ovary syndrome
Health-related quality of life
Synbiotic
Bacillus coagulans
title Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
title_full Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
title_fullStr Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
title_full_unstemmed Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
title_short Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
title_sort synbiotic as an ameliorating factor in the health related quality of life in women with polycystic ovary syndrome a randomized triple blind placebo controlled trial
topic Polycystic ovary syndrome
Health-related quality of life
Synbiotic
Bacillus coagulans
url https://doi.org/10.1186/s12905-023-02868-1
work_keys_str_mv AT zahrahariri synbioticasanamelioratingfactorinthehealthrelatedqualityoflifeinwomenwithpolycysticovarysyndromearandomizedtripleblindplacebocontrolledtrial
AT zahrayari synbioticasanamelioratingfactorinthehealthrelatedqualityoflifeinwomenwithpolycysticovarysyndromearandomizedtripleblindplacebocontrolledtrial
AT sedighehoseini synbioticasanamelioratingfactorinthehealthrelatedqualityoflifeinwomenwithpolycysticovarysyndromearandomizedtripleblindplacebocontrolledtrial
AT khadijehabhari synbioticasanamelioratingfactorinthehealthrelatedqualityoflifeinwomenwithpolycysticovarysyndromearandomizedtripleblindplacebocontrolledtrial
AT golbonsohrab synbioticasanamelioratingfactorinthehealthrelatedqualityoflifeinwomenwithpolycysticovarysyndromearandomizedtripleblindplacebocontrolledtrial